ACOR

Acorda Therapeutics, Inc. Press Releases

$35.5199
*  
0.2201
0.62%
Get ACOR Alerts
*Delayed - data as of Mar. 5, 2015 13:58 ET  -  Find a broker to begin trading ACOR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACOR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Acorda Therapeutics to Present at the Barclays Global Healthcare Conference
3/4/2015 7:00:00 AM - Business Wire


Acorda Therapeutics to Present at the Cowen 35th Annual Health Care Conference
2/23/2015 7:00:00 AM - Business Wire


Acorda Therapeutics to Present at the 2015 RBC Capital Markets’ Healthcare Conference
2/17/2015 7:00:00 AM - Business Wire


Acorda Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
2/12/2015 6:00:00 AM - Business Wire


Acorda Therapeutics to Present at the 2015 Leerink Global Healthcare Conference
2/5/2015 7:10:00 AM - Business Wire


Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2014 Financial Results on February 12, 2015
2/5/2015 7:00:00 AM - Business Wire


Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis
2/2/2015 7:01:00 AM - Business Wire


VBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors
1/20/2015 8:00:00 AM - GlobeNewswire


Acorda Provides Corporate Update at J.P. Morgan Healthcare Conference
1/12/2015 6:01:00 AM - Business Wire
▼-15.69 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/6/2015 7:00:00 AM - Business Wire
▼-11.99 % Price Change since this news event. The Volume Ratio is 1.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
12/15/2014 7:01:00 AM - Business Wire
▼-8.17 % Price Change since this news event. The Volume Ratio is 1.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda Announces Initiation of Phase 3 Trial of CVT-301 in Parkinson’s Disease
12/10/2014 7:00:00 AM - Business Wire
▼-8.41 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day